These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33977026)

  • 1. A novel homozygous variant in
    Alstrup M; Vogel I; Sandager P; Blechingberg J; Becher N; Østergaard E
    JIMD Rep; 2021 May; 59(1):20-25. PubMed ID: 33977026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.
    Feichtinger RG; Oláhová M; Kishita Y; Garone C; Kremer LS; Yagi M; Uchiumi T; Jourdain AA; Thompson K; D'Souza AR; Kopajtich R; Alston CL; Koch J; Sperl W; Mastantuono E; Strom TM; Wortmann SB; Meitinger T; Pierre G; Chinnery PF; Chrzanowska-Lightowlers ZM; Lightowlers RN; DiMauro S; Calvo SE; Mootha VK; Moggio M; Sciacco M; Comi GP; Ronchi D; Murayama K; Ohtake A; Rebelo-Guiomar P; Kohda M; Kang D; Mayr JA; Taylor RW; Okazaki Y; Minczuk M; Prokisch H
    Am J Hum Genet; 2017 Oct; 101(4):525-538. PubMed ID: 28942965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous mutations in C1QBP as cause of progressive external ophthalmoplegia (PEO) and mitochondrial myopathy with multiple mtDNA deletions.
    Marchet S; Legati A; Nasca A; Di Meo I; Spagnolo M; Zanetti N; Lamantea E; Catania A; Lamperti C; Ghezzi D
    Hum Mutat; 2020 Oct; 41(10):1745-1750. PubMed ID: 32652806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing reveals a homozygous C1QBP deletion as the cause of progressive external ophthalmoplegia and multiple mtDNA deletions.
    Guo L; Govindaraj P; Kievit M; de Coo IFM; Gerards M; Hellebrekers DMEI; Stassen APM; Gayathri N; Taly AB; Sankaran BP; Smeets HJM
    Neuromuscul Disord; 2021 Sep; 31(9):859-864. PubMed ID: 34419324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C1q Binding Protein (C1QBP): Physiological Functions, Mutation-Associated Mitochondrial Cardiomyopathy and Current Disease Models.
    Wang J; Huang CL; Zhang Y
    Front Cardiovasc Med; 2022; 9():843853. PubMed ID: 35310974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial cardiomyopathy and ventricular arrhythmias associated with biallelic variants in C1QBP.
    Webster G; Reynolds M; Arva NC; Dellefave-Castillo LM; McElligott HS; Kofman A; Laboski A; Magnetta D; George AL; McNally EM; Puckelwartz MJ
    Am J Med Genet A; 2021 Aug; 185(8):2496-2501. PubMed ID: 34003581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro.
    Hong X; Yu Z; Chen Z; Jiang H; Niu Y; Huang Z
    J Cell Biochem; 2018 Nov; 119(11):8807-8817. PubMed ID: 30159917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
    Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
    Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
    Shi H; Fang W; Liu M; Fu D
    Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
    Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
    Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Onset of Combined Oxidative Phosphorylation Deficiency in Two Chinese Brothers Caused by a Homozygous (Leu275Phe) Mutation in the
    Wang J; Li H; Sun M; Yang Y; Yang Q; Liu B; Liu F; Hu W; Zhang Y
    Front Pediatr; 2020; 8():583047. PubMed ID: 33344382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect.
    Fu RH; Tsai CW; Chiu SC; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement component 1q subcomponent binding protein in the brain of the rat.
    Barna J; Dimén D; Puska G; Kovács D; Csikós V; Oláh S; Udvari EB; Pál G; Dobolyi Á
    Sci Rep; 2019 Mar; 9(1):4597. PubMed ID: 30872665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
    Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
    Matsumoto K; Bay BH
    Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.
    Kim K; Kim MJ; Kim KH; Ahn SA; Kim JH; Cho JY; Yeo SG
    Exp Ther Med; 2017 May; 13(5):2493-2500. PubMed ID: 28565870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine reproductive and respiratory syndrome virus infection promotes C1QBP secretion to enhance inflammatory responses.
    Li Y; Wei Y; Hao W; Zhao W; Zhou Y; Wang D; Xiao S; Fang L
    Vet Microbiol; 2020 Feb; 241():108563. PubMed ID: 31928703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
    Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study.
    Monier I; Receveur A; Houfflin-Debarge V; Goua V; Castaigne V; Jouannic JM; Mousty E; Saliou AH; Bouchghoul H; Rousseau T; Valat AS; Groussolles M; Fuchs F; Benoist G; Degre S; Massardier J; Tsatsaris V; Kleinfinger P; Zeitlin J; Benachi A;
    Am J Obstet Gynecol; 2021 Dec; 225(6):676.e1-676.e15. PubMed ID: 34058167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
    Saha SK; Kim KE; Islam SMR; Cho SG; Gil M
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30991713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.